Kenvue Inc. (NYSE:KVUE) caught Jim Cramer’s attention recently. Despite litigation concerns raised by a caller, Cramer remains positive on the company’s outlook, citing past experiences with similar situations. KVUE offers a range of consumer health products, including popular brands like Tylenol and Neutrogena.

While KVUE shows promise as an investment, there are AI stocks with potentially higher returns and lower risks. For those seeking undervalued AI stocks poised to benefit from current economic trends, a free report on the best short-term AI stock is available.

Disclosure: None. This news was originally published on Insider Monkey.

Read more at Yahoo Finance: “I Think It is a Good Situation, Not a Bad One”